Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
To compare safety and efficacy of SakuraBead with corticosteroid injection for the treatment of pain secondary to knee osteoarthritis. Treatment will be performed on a total of approximately 89 patients who will be followed up for a period of 2 years.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Genicular Artery Embolization (GAE) | Experimental | Temporary Embolization of Genicular Arteries using Resorbable Microspheres |
|
| Corticosteroid Injection | Active Comparator | Corticosteroid injection in the knee |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SakuraBead Resorbable Microspheres | Device | Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres |
|
| Measure | Description | Time Frame |
|---|---|---|
| Primary Efficacy Endpoint - Proportion of Responders | Compare the proportion of responders* (defined as ≥50% reduction in WOMAC Pain** score and ≥2 point reduction in NRS***) between the Investigational procedure and Control at 6 months.
| 6 Months |
| Primary Safety Endpoint - Freedom from treatment-related SAEs | Freedom from treatment-related serious adverse events (SAE) through 6 months following the index procedure (proportions will be compared between Investigational procedure and Control). | 6 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of Responders at 1 Month and 3 Month | Compare the proportion of responders* (defined as ≥50% reduction in WOMAC Pain** score and ≥2 point reduction in NRS***) between the Investigational procedure and Control at 1 Month and 3 Months.
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Alabama Medicine | Birmingham | Alabama | 35233 | United States | ||
| Harbor UCLA Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Corticosteroid Injection | Drug | Corticosteroid injection in the knee |
|
| 1 Month and 3 Months |
| Change in mean WOMAC Pain | Compare mean change from baseline in the Western Ontario and McMaster University Osteoarthritis Index Pain (WOMAC Pain, Scale: 0-20, where a lower score represents a better outcome) between the Investigational procedure and Control at 1 Month, 3 Months and 6 Months. | 1 Month, 3 Months and 6 Months |
| Change in Numeric Rating Scale (NRS) | Compare mean decrease in pain (measured using the Numeric Rating Scale (NRS)) between the Investigational procedure and Control at 1 month, 3 months and 6 months. Scale: 0-10, where a lower score means a better outcome. | 1 Month, 3 Months and 6 Months |
| Torrance |
| California |
| 90502 |
| United States |
| Advanced Vascular Institute | Panama City | Florida | 32405 | United States |
| IR Centers | Raleigh | North Carolina | 27617 | United States |
| IR Centers | Leesburg | Virginia | 20176 | United States |
| Bokhua Memorial Cardiovascular Center | Tbilisi | Georgia |
| Royal Berkshire NHS Foundation Trust | Reading | RG1 5AN | United Kingdom |
| Nano Medical Clinic | Tashkent | Uzbekistan | 100095 | Uzbekistan |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D001168 | Arthritis |
| D010003 | Osteoarthritis |
| D020370 | Osteoarthritis, Knee |
| ID | Term |
|---|---|
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000305 | Adrenal Cortex Hormones |
| ID | Term |
|---|---|
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
Not provided
Not provided